Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature

2016 ◽  
Vol 56 (5) ◽  
pp. 493-503 ◽  
Author(s):  
William M. Greenberg ◽  
Leslie Citrome
Keyword(s):  
Systematic Review ◽  
Second Generation ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Second Generation Antipsychotic ◽  
Lurasidone Hydrochloride

scholarly journals Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis

2019 ◽  
Vol 6 (9) ◽  
pp. 753-765 ◽  
Author(s):  
Johannes Schneider-Thoma ◽  
Orestis Efthimiou ◽  
Irene Bighelli ◽  
Carola Dörries ◽  
Maximilian Huhn ◽  
...  
Keyword(s):  
Systematic Review ◽  
Adverse Events ◽  
Antipsychotic Drugs ◽  
Second Generation ◽  
Meta Analysis ◽  
Short Term ◽  
Serious Adverse Events ◽  
Second Generation Antipsychotic

scholarly journals Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons

2010 ◽  
Vol 38 (1) ◽  
pp. 167-177 ◽  
Author(s):  
Christine Rummel-Kluge ◽  
Katja Komossa ◽  
Sandra Schwarz ◽  
Heike Hunger ◽  
Franziska Schmid ◽  
...  
Keyword(s):  
Systematic Review ◽  
Side Effects ◽  
Antipsychotic Drugs ◽  
Second Generation ◽  
Meta Analysis ◽  
Extrapyramidal Side Effects ◽  
Second Generation Antipsychotic

A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania

2006 ◽  
Vol 21 (1) ◽  
pp. 1-9 ◽  
Author(s):  
R.M. Jones ◽  
C. Thompson ◽  
I. Bitter
Keyword(s):  
Systematic Review ◽  
Second Generation ◽  
Case Reports ◽  
Case Series ◽  
Antipsychotic Agents ◽  
Efficacy And Safety ◽  
Open Label ◽  
Second Generation Antipsychotics ◽  
Second Generation Antipsychotic ◽  
Randomised Controlled

AbstractSecond generation antipsychotic agents are increasingly used in the management of acute mania. A systematic review of the efficacy and safety of these agents, as both monotherapy and in combination with mood stabilisers, was performed to establish the evidence for their use. Randomised controlled trials (RCTs) were critically appraised in more detail than studies that presented lower levels of evidence such as case reports, case series and open label follow up studies. We found 11 RCTs reporting on patients treated with second generation antipsychotics for acute bipolar mania, of which three included randomisation between the second generation antipsychotic and placebo, and eight between a mood stabiliser combined with either the second generation antipsychotic or placebo. Data from non-randomised trials is also presented.

Sign in / Sign up

Export Citation Format

Share Document